Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1719 News Items found MSK Leaders Recognized in Crain’s New York Business 2020 Notable in Healthcare List Monday, August 10, 2020 The third-annual Crain’s New York Business Notable in Healthcare list celebrates outstanding individuals in the healthcare community within the New York metropolitan area, and honors their professional, civic, and philanthropic achievements. Navigating Cancer Care Throughout COVID-19 Friday, August 7, 2020 During an Information Session for patients and caregivers, a team of experts at Memorial Sloan Kettering shared their insights on navigating cancer care in the current environment. Large International Study Pinpoints Impact of TP53 Gene Mutations on Blood Cancer Severity Monday, August 3, 2020 Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering. Spotlight Speaker: SKI Director, Joan Massagué, PhD Wednesday, July 29, 2020 SKI Director, Joan Massagué, PhD, is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis. He is featured in the July 29 MSK Science Spotlight. Shining a Spotlight on Pioneering Immunologist, Alexander Rudensky, PhD Monday, July 27, 2020 The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD. Cancer Is Not Going Away During COVID-19: Physician-in-Chief Lisa DeAngelis Shares Why Patients Need to Get Back to the Clinic Friday, July 24, 2020 Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care. Finding A Never-Before-Seen Cell State May Explain Cancer’s Ability to Resist Drugs Thursday, July 23, 2020 Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability. MSK Kids and Staff Dance Through 2020 with a “Mask-erade” Prom Wednesday, July 22, 2020 MSK Kids staff made some clever tweaks and a few adjustments to host the ultimate “mask-erade” prom. Spotlight on Immunotherapy of Mismatch Repair Deficient Tumors Wednesday, July 22, 2020 The July 22 MSK Science Spotlight features Luis Diaz, MD, Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.” In the Clinic What’s New in Sarcoma Treatment? MSK Researchers Are Leading Many Innovative Clinical Trials Wednesday, July 22, 2020 MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer